机译:ISPOR Task Force For Clinical Outcomes Assessment: Clinical Outcome Assessments: Conceptual Foundation-Report of The ISPOR Clinical Outcomes Assessment - Emerging Good Practices For Outcomes Research Task Force
机译:Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research-The SIMULATE Checklist: Report of the ISPOR Simulation Modeling Emerging Good Practices Task Force
机译:Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making An ISPOR-AMCP-NPC Good Practice Task Force Report (vol 17, pg 157, 2014)
机译:Power and Sample Size Calculations in Clinical Trials with Patient-Reported Outcomes under Equal and Unequal Group Sizes Based on Graded Response Model: A Simulation Study
机译:Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group
机译:Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research Part 2: Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force
机译:Cost-Utility Analysis Comparing Propranolol With Corticosteroids in the Treatment of Proliferating Infantile Hemangioma in Italy (vol 17, pg A511, 2015)
机译:Assessing the Health-Related Quality of Life of Australian Adolescents: An Empirical Comparison of the Child Health Utility 9D and EQ-5D-Y Instruments
机译:Cost-Utility Analysis Comparing Propranolol With Corticosteroids in the Treatment of Proliferating Infantile Hemangioma in Italy (vol 17, pg A511, 2015)
机译:Using classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examples (vol 18, pg 25, 2015)
机译:Applying dynamic simulation modeling methods in health care delivery research-the SIMULATE Checklist: report of the ISPOR Simulation Modeling Emerging Good Practices Task Force (vol 18, pg 5, 2015)
机译:Critical Appraisal of Network Meta-Analyses Evaluating the Efficacy and Safety of New Oral Anticoagulants in Atrial Fibrillation Stroke Prevention Trials
机译:Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer: A Value of Information Analysis
机译:Implications of the Minimal Clinically Important Difference for Health-Related Quality-of-Life Outcomes: A Comparison of Sample Size Requirements for an Incontinence Treatment Trial
机译:Effectiveness and Content Analysis of Interventions to Enhance Oral Antidiabetic Drug Adherence in Adults with Type 2 Diabetes: Systematic Review and Meta-Analysis
机译:Some Cautions on the Use of Instrumental Variables Estimators in Outcomes Research: How Bias in Instrumental Variables Estimators Is Affected by Instrument Strength, Instrument Contamination, and Sample Size
机译:Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales
机译:Update to the Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for Five Health-Related Quality-of-Life Scores
机译:Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry
机译:Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy